Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin

Translated title of the contribution: Pharmacokinetics and pharmacodynamics of antibiotics in intensive care

F. Sorgel, R. Höhl, R. Glaser, C. Stelzer, M. Munz, M. Vormittag, M. Kinzig, J. Bulitta, C. Landersdorfer, A. Junger, M. Christ, M. Wilhelm, U. Holzgrabe

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Optimized dosage regimens of antibiotics have remained obscure since their introduction. During the last two decades pharmacokinetic(PK)-pharmacodynamic(PD) relationships, originally established in animal experiments, have been increasingly used in patients. The action of betalactams is believed to be governed by the time the plasma concentration is above the minimum inhibitory concentration (MIC). Aminoglycosides act as planned when the peak concentration is a multiple of the MIC and vancomycin seems to work best when the area under the plasma vs. time curve (AUC) to MIC has a certain ratio. Clinicians should be aware that these relationships can only be an indication in which direction dosing should go. Larger studies with sufficiently high numbers of patients and particularly severely sick patients are needed to prove the concepts. In times where all antibiotics can be measured with new technologies, the introduction of therapeutic drug monitoring (TDM) is suggested for ICUs (Intensive Care Unit). The idea of a central lab for TDM of antibiotics such as PEAK (Paul Ehrlich Antibiotika Konzentrationsmessung) is supported.

Original languageGerman
Pages (from-to)11-22
Number of pages12
JournalMedizinische Klinik - Intensivmedizin und Notfallmedizin
Volume112
Issue number1
DOIs
Publication statusPublished - Feb 2017

Keywords

  • Antibiotics
  • Critically ill
  • Mass spectrometry
  • Penicillin
  • Therapeutic drug monitoring

Cite this

Sorgel, F., Höhl, R., Glaser, R., Stelzer, C., Munz, M., Vormittag, M., ... Holzgrabe, U. (2017). Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin. Medizinische Klinik - Intensivmedizin und Notfallmedizin, 112(1), 11-22. https://doi.org/10.1007/s00063-016-0185-5
Sorgel, F. ; Höhl, R. ; Glaser, R. ; Stelzer, C. ; Munz, M. ; Vormittag, M. ; Kinzig, M. ; Bulitta, J. ; Landersdorfer, C. ; Junger, A. ; Christ, M. ; Wilhelm, M. ; Holzgrabe, U. / Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin. In: Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2017 ; Vol. 112, No. 1. pp. 11-22.
@article{19066a28c1ff4aaaae9affa60fd62f2c,
title = "Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin",
abstract = "Optimized dosage regimens of antibiotics have remained obscure since their introduction. During the last two decades pharmacokinetic(PK)-pharmacodynamic(PD) relationships, originally established in animal experiments, have been increasingly used in patients. The action of betalactams is believed to be governed by the time the plasma concentration is above the minimum inhibitory concentration (MIC). Aminoglycosides act as planned when the peak concentration is a multiple of the MIC and vancomycin seems to work best when the area under the plasma vs. time curve (AUC) to MIC has a certain ratio. Clinicians should be aware that these relationships can only be an indication in which direction dosing should go. Larger studies with sufficiently high numbers of patients and particularly severely sick patients are needed to prove the concepts. In times where all antibiotics can be measured with new technologies, the introduction of therapeutic drug monitoring (TDM) is suggested for ICUs (Intensive Care Unit). The idea of a central lab for TDM of antibiotics such as PEAK (Paul Ehrlich Antibiotika Konzentrationsmessung) is supported.",
keywords = "Antibiotics, Critically ill, Mass spectrometry, Penicillin, Therapeutic drug monitoring",
author = "F. Sorgel and R. H{\"o}hl and R. Glaser and C. Stelzer and M. Munz and M. Vormittag and M. Kinzig and J. Bulitta and C. Landersdorfer and A. Junger and M. Christ and M. Wilhelm and U. Holzgrabe",
year = "2017",
month = "2",
doi = "10.1007/s00063-016-0185-5",
language = "German",
volume = "112",
pages = "11--22",
journal = "Medizinische Klinik - Intensivmedizin und Notfallmedizin",
issn = "2193-6218",
publisher = "Springer-Verlag London Ltd.",
number = "1",

}

Sorgel, F, Höhl, R, Glaser, R, Stelzer, C, Munz, M, Vormittag, M, Kinzig, M, Bulitta, J, Landersdorfer, C, Junger, A, Christ, M, Wilhelm, M & Holzgrabe, U 2017, 'Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin', Medizinische Klinik - Intensivmedizin und Notfallmedizin, vol. 112, no. 1, pp. 11-22. https://doi.org/10.1007/s00063-016-0185-5

Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin. / Sorgel, F.; Höhl, R.; Glaser, R.; Stelzer, C.; Munz, M.; Vormittag, M.; Kinzig, M.; Bulitta, J.; Landersdorfer, C.; Junger, A.; Christ, M.; Wilhelm, M.; Holzgrabe, U.

In: Medizinische Klinik - Intensivmedizin und Notfallmedizin, Vol. 112, No. 1, 02.2017, p. 11-22.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin

AU - Sorgel, F.

AU - Höhl, R.

AU - Glaser, R.

AU - Stelzer, C.

AU - Munz, M.

AU - Vormittag, M.

AU - Kinzig, M.

AU - Bulitta, J.

AU - Landersdorfer, C.

AU - Junger, A.

AU - Christ, M.

AU - Wilhelm, M.

AU - Holzgrabe, U.

PY - 2017/2

Y1 - 2017/2

N2 - Optimized dosage regimens of antibiotics have remained obscure since their introduction. During the last two decades pharmacokinetic(PK)-pharmacodynamic(PD) relationships, originally established in animal experiments, have been increasingly used in patients. The action of betalactams is believed to be governed by the time the plasma concentration is above the minimum inhibitory concentration (MIC). Aminoglycosides act as planned when the peak concentration is a multiple of the MIC and vancomycin seems to work best when the area under the plasma vs. time curve (AUC) to MIC has a certain ratio. Clinicians should be aware that these relationships can only be an indication in which direction dosing should go. Larger studies with sufficiently high numbers of patients and particularly severely sick patients are needed to prove the concepts. In times where all antibiotics can be measured with new technologies, the introduction of therapeutic drug monitoring (TDM) is suggested for ICUs (Intensive Care Unit). The idea of a central lab for TDM of antibiotics such as PEAK (Paul Ehrlich Antibiotika Konzentrationsmessung) is supported.

AB - Optimized dosage regimens of antibiotics have remained obscure since their introduction. During the last two decades pharmacokinetic(PK)-pharmacodynamic(PD) relationships, originally established in animal experiments, have been increasingly used in patients. The action of betalactams is believed to be governed by the time the plasma concentration is above the minimum inhibitory concentration (MIC). Aminoglycosides act as planned when the peak concentration is a multiple of the MIC and vancomycin seems to work best when the area under the plasma vs. time curve (AUC) to MIC has a certain ratio. Clinicians should be aware that these relationships can only be an indication in which direction dosing should go. Larger studies with sufficiently high numbers of patients and particularly severely sick patients are needed to prove the concepts. In times where all antibiotics can be measured with new technologies, the introduction of therapeutic drug monitoring (TDM) is suggested for ICUs (Intensive Care Unit). The idea of a central lab for TDM of antibiotics such as PEAK (Paul Ehrlich Antibiotika Konzentrationsmessung) is supported.

KW - Antibiotics

KW - Critically ill

KW - Mass spectrometry

KW - Penicillin

KW - Therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=84992215904&partnerID=8YFLogxK

U2 - 10.1007/s00063-016-0185-5

DO - 10.1007/s00063-016-0185-5

M3 - Article

VL - 112

SP - 11

EP - 22

JO - Medizinische Klinik - Intensivmedizin und Notfallmedizin

JF - Medizinische Klinik - Intensivmedizin und Notfallmedizin

SN - 2193-6218

IS - 1

ER -